SIP
AXDX

Stoneridge Investment Partners’s Accelerate Diagnostics AXDX Stock Holding History

Stoneridge Investment Partners’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-2,333
Closed -$335K – 282
2016
Q1 		$335K Buy
+2,333
New +$329K 0.05% 235
2015
Q4 		– Sell
-1,628
Closed -$263K – 278
2015
Q3 		$263K Buy
+1,628
New +$352K 0.04% 247

Other funds holding AXDX

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
MGM
Miura Global Management New York $43.8M AUM 53.8% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stoneridge Investment Partners's AXDX Position: Q2 2016 in Review

Stoneridge Investment Partners sold out of Accelerate Diagnostics (AXDX) in Q2 2016, closing a stake of 2,333 shares — an estimated $335K sold.

Stoneridge Investment Partners first reported a position in AXDX in Q3 2015 and held it in 2 quarters. The position peaked at $335K in Q1 2016. 95 funds tracked by Wall St. Rank hold AXDX as of Q2 2016.

  • Stoneridge Investment Partners reported no remaining Accelerate Diagnostics position as of Q2 2016 after selling out during the quarter.
  • Stoneridge Investment Partners sold 2,333 Accelerate Diagnostics shares in Q2 2016, an estimated $335K.
  • Stoneridge Investment Partners first reported a position in Accelerate Diagnostics in Q3 2015 and held it in 2 quarters.
  • Stoneridge Investment Partners's Accelerate Diagnostics position peaked at $335K in Q1 2016.
  • 95 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2016.

Based on Stoneridge Investment Partners's 13F filing for Q2 2016, filed 25 Jul 2016.